 |
 |

Response to Levodopa Treatment in Dopa-Responsive Dystonia
John G. Nutt, MD;
Torbjoern G. Nygaard, MD
Arch Neurol. 2001;58:905-910.
Background Dopa-responsive dystonia (DRD) is similar to Parkinson disease in that
both disorders have impaired dopamine synthesis and respond to levodopa treatment.
Dopa-responsive dystonia differs in that dopamine storage is intact in contrast
to Parkinson disease in which it is markedly reduced.
Objective To examine the short- and long-duration responses to levodopa dosing
in subjects with DRD.
Methods The response to brief infusions of levodopa was examined in 4 subjects
with DRD and the effects of withdrawal of levodopa for 3 to 7 days studied
in the 3 subjects receiving long-term levodopa therapy. Motor function was
measured with tapping speed, Unified Parkinson's Disease Rating Scale motor
score, and global dystonia score.
Results The short-duration response to levodopa dosing seems to develop more
slowly and persists longer in subjects with DRD than in subjects with Parkinson
disease. Withdrawal of levodopa leads to a gradual decline in tapping speed
and reemergence of dystonia over several days, similar to the rate of decay
of motor function in Parkinson disease. The short- and long-duration responses
were not clearly differentiated in DRD.
Conclusions This pilot study suggests that retained dopamine storage in DRD may
prolong the short-duration response and blur the distinction of the short-
and long-duration responses. The decline in motor function in DRD on withdrawal
of long-term levodopa therapy resembles that in Parkinson disease, suggesting
that a long-duration response, if it exists in DRD, is unrelated to dopamine
storage.
From the Departments of Neurology and Physiology and Pharmacology,
Oregon Health Sciences University, Portland (Dr Nutt); Department of Neurology,
East Orange Veterans Affairs Medical Center, East Orange, NJ (Dr Nygaard);
and the Department of Neurosciences, University of Medicine and DentistryNew
Jersey Medical School, Newark, NJ (Dr Nygaard).
Corresponding author: John G. Nutt, MD, Department of Neurology,
OP 32, Oregon Health Sciences University, 3181 SW Sam Jackson Park Rd, Portland,
OR 97201-3098.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Intracortical inhibition of the motor cortex in Segawa disease (DYT5)
Hanajima et al.
Neurology 2007;68:1039-1044.
ABSTRACT
| FULL TEXT
Broadening the Phenotype of Childhood-Onset Dopa-Responsive Dystonia.
Chaila et al.
Arch Neurol 2006;63:1185-1188.
ABSTRACT
| FULL TEXT
Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.
Wider et al.
Arch Neurol 2006;63:951-955.
ABSTRACT
| FULL TEXT
Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model
de la Fuente-Fernandez et al.
Brain 2004;127:888-899.
ABSTRACT
| FULL TEXT
|